Expert panelists will delve into where America stands in public health a year into the COVID-19 pandemic. They will discuss how the COVID-19 pandemic has shaped clinical care, state preparedness, and the individual consumer experience and shed light on promising frameworks and infrastructures being built today to protect Americans from a major public health emergency tomorrow.
This briefing provided an overview of the Medicare Trust Funds, the nuances of solvency, and the consequences of not resolving funding shortfalls. Panelists explored short- and long-term policy options to address solvency and offer equitable access, as well as the potential impacts on providers, plans, and most importantly, Medicare beneficiaries.
This briefing provided a high-level overview of the budget reconciliation process and also discussed potential applications of reconciliation to address national economic and health policy concerns of the 117th Congress and the new administration.
Attendees learned the challenges and opportunities states face in safe and timely vaccine deployment and supply management, plans states are executing to ensure equitable vaccine distribution, and plans states are executing to ensure equitable vaccine distribution along the way.
This briefing explored the current state of COVID-19 vaccine deployment efforts, cultural, historical, and political influences that may generate feelings of hesitancy, and how to ensure optimal vaccine uptake in key populations.
If you have a funded fellowship or scholarship and are looking for a host organization, the Alliance welcomes attentive and proactive students interested in health policy to join our team as a fellow.
Dr. Stephen Hahn addressed the role of the U.S. Food and Drug Administration in the COVID-19 response and best practices and lessons learned from the emergency response to date.
This discussion focused on measures industry stakeholders have taken for safe COVID-19 vaccine deployment and the immediate steps these stakeholders will take in the first 48 hours after the Emergency Use Authorization was approved.
This briefing explored how our supply chain must respond to manufacture millions of doses and then swiftly deliver them to administration sites. Panelists also illustrated the steps these stakeholders might take in the first 48 hours after an Emergency Use Authorization is approved.
This was the final event in Part II of our Signature Series focusing on the voice of the patient. This briefing explored the rise of consumer wearables as increasingly prevalent tools in health care delivery and as part of patient care plans.
This briefing provided an overview of how census data is collected, analyzed, and utilized, with a particular focus on how this process impacts health policy and public health.
Sessions on Day 2 of the Post Election Symposium included a fireside chat with futurist Ian Morrison and leaders from the ground discussed the long-term vision for rebuilding the health system.
Sessions on Day 1 of the Post Election Symposium provided an analysis of the election results and potential impacts for health care and a discussion on the gaps in our health care system that COVID-19 exposed.
Two days after the oral arguments for Texas v. California, this panel will provide an overview of the arguments and questions posed while also addressing procedural next steps.
This briefing will overview the complex ecosystem of federal, state, and private programs that coexist to integrate medical, LTSS, and social services for low-income seniors.
Day 3 of our Voice of the Patient Summit, a program of the 2020 Signature Series, will address how we collect and operationalize patient feedback to create patient-centered care at a systems level.
Day 2 of our Voice of the Patient Summit, a program of the 2020 Signature Series, will explore successful mechanisms to support patients navigate the current, highly complex health care system and foster independence in decision making.
Day 1 of our Voice of the Patient Summit, a program of the 2020 Signature Series, includes an opening keynote presentation and panel focusing on strategies for effective communication and shared decision making from the patient and caregiver perspectives.
During this Summit, we will examine the patient’s voice across several levels of health care design, delivery, and measurement. This event is part of our ongoing 2020 Signature Series focusing on the Voice of the Patient.
The COVID-19 pandemic has exposed both new and longstanding needs of long-term care patients. Experts will overview the recent changes, remaining gaps, and benefits and risks to long-term care patients, caregivers, providers, and payers.
This is the final event in Part I of our Signature Series focusing on disruptors and transformers in health care. This briefing explored the manufacturing, distribution, delivery, and coverage approaches that will enable nationwide COVID-19 vaccine uptake.
November 16-17 | This virtual symposium will gather a range of experts after election day to discuss how the results could influence the health policy agenda in 2021 and beyond.
Dr. Anand Shah provided opening remarks and answered questions about the U.S. Food and Drug Administration’s role in the national COVID-19 response.
This solutions-focused discussion explored policy interventions at the federal, state, and local levels to advance mental health during the ongoing pandemic.
During this on-the-record briefing for reporters, Dr. Anthony S. Fauci, Director, National Institute of Allergy and Infectious Disease at the National Institutes of Health provided insight into the status of the COVID-19 pandemic. Dr. Fauci discussed the status of spread of the virus in the United States and highlighted progress toward successful treatments and vaccines.